Structure-based screening and optimization of cytisine derivatives as inhibitors of the menin–MLL interaction
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structure-based screening and optimization of cytisine derivatives as inhibitors of the menin–MLL interaction
Authors
Keywords
-
Journal
CHEMICAL COMMUNICATIONS
Volume 52, Issue 34, Pages 5788-5791
Publisher
Royal Society of Chemistry (RSC)
Online
2016-03-10
DOI
10.1039/c6cc01079b
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacologic Inhibition of the Menin-MLL Interaction Blocks Progression of MLL Leukemia In Vivo
- (2015) Dmitry Borkin et al. CANCER CELL
- Structure-based discovery of an immunomodulatory inhibitor of TLR1–TLR2 heterodimerization from a natural product-like database
- (2015) Zhangfeng Zhong et al. CHEMICAL COMMUNICATIONS
- Successful strategies in the discovery of small-molecule epigenetic modulators with anticancer potential
- (2015) Juan Bayo et al. Future Medicinal Chemistry
- Natural products as a source of drug leads to overcome drug resistance
- (2015) Lynn L Silver Future Microbiology
- Biochemical Reconstitution and Phylogenetic Comparison of Human SET1 Family Core Complexes Involved in Histone Methylation
- (2015) Stephen A. Shinsky et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- In silico identification of natural product inhibitors of JAK2
- (2015) Hai-Jing Zhong et al. METHODS
- Discovery of deoxyvasicinone derivatives as inhibitors of NEDD8-activating enzyme
- (2015) Hai-Jing Zhong et al. METHODS
- Virtual screening and optimization of Type II inhibitors of JAK2 from a natural product library
- (2014) Dik-Lung Ma et al. CHEMICAL COMMUNICATIONS
- Challenges and opportunities in targeting the menin–MLL interaction
- (2014) Tomasz Cierpicki et al. Future Medicinal Chemistry
- Targeting protein-protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies?
- (2014) Tomasz Cierpicki et al. IMMUNOLOGICAL REVIEWS
- The functional and mechanistic relatedness of EZH2 and menin in hepatocellular carcinoma
- (2014) Shu-Bin Gao et al. JOURNAL OF HEPATOLOGY
- High-Affinity Small-Molecule Inhibitors of the Menin-Mixed Lineage Leukemia (MLL) Interaction Closely Mimic a Natural Protein–Protein Interaction
- (2014) Shihan He et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of a natural product-like STAT3 dimerization inhibitor by structure-based virtual screening
- (2014) L-J Liu et al. Cell Death & Disease
- SET1 and p300 Act Synergistically, through Coupled Histone Modifications, in Transcriptional Activation by p53
- (2013) Zhanyun Tang et al. CELL
- Menin promotes hepatocellular carcinogenesis and epigenetically up-regulates Yap1 transcription
- (2013) B. Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Visualization of cofilin-actin and Ras-Raf interactions by bimolecular fluorescence complementation assays using a new pair of split Venus fragments
- (2012) Kazumasa Ohashi et al. BIOTECHNIQUES
- Structural insights into inhibition of the bivalent menin-MLL interaction by small molecules in leukemia
- (2012) A. Shi et al. BLOOD
- Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia
- (2012) Jolanta Grembecka et al. Nature Chemical Biology
- Trithorax group proteins: switching genes on and keeping them active
- (2011) Bernd Schuettengruber et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Menin Critically Links MLL Proteins with LEDGF on Cancer-Associated Target Genes
- (2008) Akihiko Yokoyama et al. CANCER CELL
- Menin, Histone H3 Methyltransferases, and Regulation of Cell Proliferation: Current Knowledge and Perspective
- (2008) Xinjiang Wu et al. CURRENT MOLECULAR MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now